These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27115358)

  • 21. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemic and control strategy on nosocomial outbreak of norovirus gastroenteritis].
    Xu Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):614-7. PubMed ID: 19024398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Norovirus: Experimental Models of Infection.
    Todd KV; Tripp RA
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30759780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.
    Payne DC; Parashar UD; Lopman BA
    Curr Opin Pediatr; 2015 Feb; 27(1):105-9. PubMed ID: 25490691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New interventions against human norovirus: progress, opportunities, and challenges.
    Li J; Predmore A; Divers E; Lou F
    Annu Rev Food Sci Technol; 2012; 3():331-52. PubMed ID: 22385167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus.
    Liu G; Kahan SM; Jia Y; Karst SM
    J Virol; 2009 Jul; 83(13):6963-8. PubMed ID: 19403675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action to prevent the spread of norovirus infection.
    Hairon N
    Nurs Times; 2008 Jan 15-21; 104(2):27-8. PubMed ID: 18277750
    [No Abstract]   [Full Text] [Related]  

  • 28. Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ.
    Ingle H; Lee S; Ai T; Orvedahl A; Rodgers R; Zhao G; Sullender M; Peterson ST; Locke M; Liu TC; Yokoyama CC; Sharp B; Schultz-Cherry S; Miner JJ; Baldridge MT
    Nat Microbiol; 2019 Jul; 4(7):1120-1128. PubMed ID: 30936486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norovirus.
    Mckay L
    Nurs Stand; 2009 Mar 25-31; 23(29):59-60. PubMed ID: 19385402
    [No Abstract]   [Full Text] [Related]  

  • 30. Foodborne viral gastroenteritis: challenges and opportunities.
    Bresee JS; Widdowson MA; Monroe SS; Glass RI
    Clin Infect Dis; 2002 Sep; 35(6):748-53. PubMed ID: 12203173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capturing norovirus transmission.
    de Graaf M; Villabruna N; Koopmans MP
    Curr Opin Virol; 2017 Feb; 22():64-70. PubMed ID: 28056379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Depth Breadth Analyses of Human Blockade Responses to Norovirus and Response to Vaccination.
    Haynes J; Perry V; Benson E; Meeks A; Watts G; Watkins H; Braun R
    Viruses; 2019 Apr; 11(5):. PubMed ID: 31035476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norovirus.
    Allen D
    Nurs Stand; 2011 Feb 16-22; 25(24):59-60. PubMed ID: 21417182
    [No Abstract]   [Full Text] [Related]  

  • 34. No! When the immunologist becomes a virologist: Norovirus - an emerging infection in immune deficiency diseases.
    Hartono S; Bhagia A; Joshi AY
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):557-564. PubMed ID: 27755184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral shape-shifting: norovirus evasion of the human immune system.
    Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
    Nat Rev Microbiol; 2010 Mar; 8(3):231-41. PubMed ID: 20125087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential economic value of a human norovirus vaccine for the United States.
    Bartsch SM; Lopman BA; Hall AJ; Parashar UD; Lee BY
    Vaccine; 2012 Nov; 30(49):7097-104. PubMed ID: 23026689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings.
    MacCannell T; Umscheid CA; Agarwal RK; Lee I; Kuntz G; Stevenson KB;
    Infect Control Hosp Epidemiol; 2011 Oct; 32(10):939-69. PubMed ID: 21931246
    [No Abstract]   [Full Text] [Related]  

  • 38. [Noroviruses: leading cause of gastroenteritis].
    Delacour H; Dubrous P; Koeck JL
    Med Trop (Mars); 2010 Apr; 70(2):111-8. PubMed ID: 20486340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.
    Lopman BA; Steele D; Kirkwood CD; Parashar UD
    PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norovirus vaccines: Correlates of protection, challenges and limitations.
    Melhem NM
    Hum Vaccin Immunother; 2016 Jul; 12(7):1653-69. PubMed ID: 26836766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.